Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...

Sanofi is buying an immunology drug from Dren Bio, Inc. for up to $1.9 billion, in a deal it said will help it become a ...

Frey announced the agreement with Sanofi-Aventis U.S. LLC after scrutiny over the company’s pricing of insulin products. “Insulin is life-sustaining medication and far too many Mainers ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Along with Le Fur – who was CEO at Sanofi predecessor Sanofi-Aventis in 2007 and 2008 – eureKING's backers include Michael Kloss, former head of Panasonic Healthcare, who will serve as CEO of ...

Has consulted for Sangamo Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; sanofi-aventis; Novartis Pharmaceuticals Corporation (all compassionate use; unpaid); Foundation for the ...

Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the company’s pricing of insulin products. Under the ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...

HighTower Advisors LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The ...

Purdue Pharma has filed a Chapter 11 Plan of Reorganization and related disclosure statement with the US Bankruptcy Court for ...

The Indian subsidiary of US pharma major Eli Lilly (NYSE: LLY) has announced the launch of Mounjaro (tirzepatide) in ...

Sanofi to acquire Dren Bio's B-cell depleting antibody DR-0201 for $600M upfront, targeting cancer and autoimmune diseases, ...